Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Sales $ 282 $ 57
Cost of goods sold 234 45
Gross profit 48 12
Operating expenses:    
Research and development 1,948 432
Selling, general and administrative 22,259 8,294
Total operating expenses 24,207 8,726
Loss from operations (24,159) (8,714)
Other income (expense):    
Management fee income 30 20
Convertible Notes fair value adjustment 0 (299)
Interest expense, net (1,643) (405)
Net loss $ (25,772) $ (9,398)
Net loss applicable to common stockholders per basic common share:    
Basic (in dollars per share) $ (0.32) $ (0.19)
Diluted (in dollars per share) $ (0.32) $ (0.19)
Weighted average common shares outstanding:    
Basic (in shares) 81,009,268 49,131,554
Diluted (in shares) 81,009,268 49,131,554